Kevin P. Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kevin P. Jiang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Paul Yager
Department of Bioengineering, University of Washington, Seattle, WA 98105, USA
2 shared publicationsSteven Bennett
Department of Bioengineering, University of Washington, Seattle, Washington, United States of America
2 shared publications- Sujatha Kumar
Department of Bioengineering, University of Washington, Seattle, WA 98105, USA
2 shared publications Erin K. Heiniger
Department of Bioengineering, University of Washington, Seattle, WA 98105, USA
1 shared publication- Erin K. Heiniger
Department of Bioengineering, University of Washington, Seattle, Washington, United States of America
1 shared publication - Paul Yager
Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States
1 shared publication
Latest Publications
- Open Access
- 15 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0344750
Heat-actuated valve implementation in a point-of-care, paper-based microfluidic device for infectious disease detection
Paper-based microfluid devices have great potential to perform complex assays like nucleic acid amplification tests (NAATs) in point-of-care (POC) and low resource settings, but have not often succeeded because there is frequently need for affordable and simple solutions to address complex fluidics and sample delivery without risk of contamination. These issues are exacerbated when multiple sample processing procedures must be automated by valve integration in the absence of advanced supportive instrumentation or trained personnel. For NAAT application in remote or home environments, valving within a POC device must facilitate precise fluidic movement and physically separate each chemical processing step. Ideally, the valve should also be affordable, easy to manufacture, robust in varying climate environments, reliable when stored under ambient conditions, affordable, and non-reactive with chemical reagents or samples. Here, we report the design and integration of two adaptable thermally-actuated valves for application in a point-of-care, paper-based rapid analysis device. Both valves are designed to facilitate the fluidic movement and control necessary to enable reverse-transcriptase loop-mediated isothermal amplification (RT-LAMP) reactions in a paper-based device. Each valve could be used independently or alongside the other valve to control fluidic movement at specific locations along the paper fluidic pathway. The valves differ in their material composition, fabrication, and mechanisms for fluidic control, but both are affordable, durable, and simple to use. We demonstrated that each valve could be used to enable RT-LAMP reactions in a paper-based device for detecting either RNA or DNA biomarkers for respiratory infectious diseases (COVID and Flu A) from human nasal swabs.
- 15 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0344750
Open AccessHeat-actuated valve implementation in a point-of-care, paper-based microfluidic device for infectious disease detection
Paper-based microfluid devices have great potential to perform complex assays like nucleic acid amplification tests (NAATs) in point-of-care (POC) and low resource settings, but have not often succeeded because there is frequently need for affordable and simple solutions to address complex fluidics and sample delivery without risk of contamination. These issues are exacerbated when multiple sample processing procedures must be automated by valve integration in the absence of advanced supportive instrumentation or trained personnel. For NAAT application in remote or home environments, valving within a POC device must facilitate precise fluidic movement and physically separate each chemical processing step. Ideally, the valve should also be affordable, easy to manufacture, robust in varying climate environments, reliable when stored under ambient conditions, affordable, and non-reactive with chemical reagents or samples. Here, we report the design and integration of two adaptable thermally-actuated valves for application in a point-of-care, paper-based rapid analysis device. Both valves are designed to facilitate the fluidic movement and control necessary to enable reverse-transcriptase loop-mediated isothermal amplification (RT-LAMP) reactions in a paper-based device. Each valve could be used independently or alongside the other valve to control fluidic movement at specific locations along the paper fluidic pathway. The valves differ in their material composition, fabrication, and mechanisms for fluidic control, but both are affordable, durable, and simple to use. We demonstrated that each valve could be used to enable RT-LAMP reactions in a paper-based device for detecting either RNA or DNA biomarkers for respiratory infectious diseases (COVID and Flu A) from human nasal swabs.
- Open Access
- 12 August 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (19) , 4414-4426
A low-cost point-of-care device for the simultaneous detection of two sexually transmitted bacterial pathogens in vaginal swab samples
Technology-driven screening improvements for the globally widespread sexually transmitted infections (STIs) caused by the bacteria Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) can improve treatment rates and decrease transmission.
- 12 August 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (19) , 4414-4426
Open AccessA low-cost point-of-care device for the simultaneous detection of two sexually transmitted bacterial pathogens in vaginal swab samples
Technology-driven screening improvements for the globally widespread sexually transmitted infections (STIs) caused by the bacteria Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) can improve treatment rates and decrease transmission.
- 12 December 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (3) , 492-504
UbiNAAT: a multiplexed point-of-care nucleic acid diagnostic platform for rapid at-home pathogen detection
The COVID-19 pandemic increased demands for respiratory disease testing to facilitate treatment and limit transmission, demonstrating in the process that most existing test options were too complex and expensive to perform in point-of-care or home scenarios. Lab-based molecular techniques can detect viral RNA in respiratory illnesses but are expensive and require trained personnel, while affordable antigen-based home tests lack sensitivity for early detection in newly infected or asymptomatic individuals. The few home RNA detection tests deployed were prohibitively expensive. Here, we demonstrate a point-of-care, paper-based rapid analysis device that simultaneously detects multiple viral RNAs; it is demonstrated on two common respiratory viruses (COVID-19 and influenza A) spiked onto a commercial nasal swab. The automated device requires no sample preparation by the user after insertion of the swab, minimizing user operation steps. We incorporated lyophilized amplification reagents immobilized in a porous matrix, a novel thermally actuated valve for multiplexed fluidic control, a printed circuit board that performs on-device lysis and amplification within a cell-phone-sized disposable device. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) products are visualized via fluorescent dyes using a modified cell phone, resulting in detection of as few as 104 viral copies per swab across both pathogens within 30 minutes. This integrated platform could be commercialized in a form that would be inexpensive, portable, and sensitive; it can readily be multiplexed to detect as many as 8 different RNA or DNA sequences, and adapted to any desired RNA or DNA detection assays.
- 12 December 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (3) , 492-504
UbiNAAT: a multiplexed point-of-care nucleic acid diagnostic platform for rapid at-home pathogen detection
The COVID-19 pandemic increased demands for respiratory disease testing to facilitate treatment and limit transmission, demonstrating in the process that most existing test options were too complex and expensive to perform in point-of-care or home scenarios. Lab-based molecular techniques can detect viral RNA in respiratory illnesses but are expensive and require trained personnel, while affordable antigen-based home tests lack sensitivity for early detection in newly infected or asymptomatic individuals. The few home RNA detection tests deployed were prohibitively expensive. Here, we demonstrate a point-of-care, paper-based rapid analysis device that simultaneously detects multiple viral RNAs; it is demonstrated on two common respiratory viruses (COVID-19 and influenza A) spiked onto a commercial nasal swab. The automated device requires no sample preparation by the user after insertion of the swab, minimizing user operation steps. We incorporated lyophilized amplification reagents immobilized in a porous matrix, a novel thermally actuated valve for multiplexed fluidic control, a printed circuit board that performs on-device lysis and amplification within a cell-phone-sized disposable device. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) products are visualized via fluorescent dyes using a modified cell phone, resulting in detection of as few as 104 viral copies per swab across both pathogens within 30 minutes. This integrated platform could be commercialized in a form that would be inexpensive, portable, and sensitive; it can readily be multiplexed to detect as many as 8 different RNA or DNA sequences, and adapted to any desired RNA or DNA detection assays.